Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.

Edouard Ledent,Hugo Arlegui,Hubert Buyse,Peter Basile,Naveen Karkada,Nicolas Praet,Gaëlle Nachbaur

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy（2018）

引用 12|浏览7

暂无评分

摘要

The vaccine-prevented RVGE hospitalizations and deaths (benefit) greatly outweigh the excess potentially vaccination-related cases of intussusception (risk), indicating a favorable benefit-risk balance for Rotarix in France.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要